Lisa Vaughan

发表

The Changing Incidence and Presentation of Urinary Stones Over 3 Decades

Lisa E. Vaughan, A. Rule, C. McCollough, 2018, Mayo Clinic proceedings.

Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney

Lisa E. Vaughan, A. Rule, M. Stegall, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.

Michael J. Miller, A. Weaver, B. Borah, 2016, American journal of obstetrics and gynecology.

24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D−mediated Hypercalcemia Disorders

Lisa E. Vaughan, David J Sas, P. Tebben, 2021, Journal of the Endocrine Society.

Kidney Function After the First Kidney Stone Event.

A. Rule, T. Vrtiska, J. Lieske, 2016, Mayo Clinic proceedings.

Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.

Lisa E. Vaughan, A. Rule, J. Lieske, 2015, Mayo Clinic proceedings.

Perinatal Outcomes with Tamsulosin Therapy for Symptomatic Urolithiasis.

A. Krambeck, Lisa Vaughan, C. Rose, 2016, The Journal of urology.

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

D. Landsittel, K. Bae, T. Kline, 2020, JCI insight.

Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial.

Marie E. Edwards, Lisa E. Vaughan, W. Kremers, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease.

W. Kremers, N. LaRusso, J. Glockner, 2015, Mayo Clinic proceedings.

Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy.

Lisa E. Vaughan, S. Ansell, M. Hathcock, 2022, Mayo Clinic proceedings.

Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease

Marie E. Edwards, Lisa E. Vaughan, W. Kremers, 2019, Mayo Clinic proceedings. Innovations, quality & outcomes.

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.

Lisa E. Vaughan, A. Rule, J. Lieske, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single‐center analysis

S. Markovic, J. Herrmann, C. Thongprayoon, 2020, Cancer.

The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study

Lisa E. Vaughan, A. Rule, F. Fervenza, 2017, Mayo Clinic proceedings.

Electronic Algorithm Is Superior to Hospital Discharge Codes for Diagnoses of Hypertensive Disorders of Pregnancy in Historical Cohorts

A. Weaver, M. Mielke, W. White, 2018, Mayo Clinic proceedings.

Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis

Michael J. Miller, Lisa E. Vaughan, A. Weaver, 2017, American journal of obstetrics and gynecology.

Cohort profile: the Olmsted County hypertensive disorders of pregnancy (HDP) cohort using the Rochester Epidemiology Project

Lisa E. Vaughan, S. Bielinski, M. Mielke, 2022, BMJ Open.

Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney Stones.

Lisa E. Vaughan, A. Rule, J. Lieske, 2022, Mayo Clinic proceedings.

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy.

Lisa E. Vaughan, R. Albright, L. Hickson, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

A. Rule, J. Lieske, F. Enders, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

A. Rule, T. Vrtiska, J. Lieske, 2015, Urology.

The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy

Lisa E. Vaughan, R. Glassock, L. Cornell, 2021 .

Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events

Lisa E. Vaughan, J. Lieske, S. Markovic, 2021, Kidney international reports.

Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.

J. Lieske, D. Milliner, F. Enders, 2017, Clinical biochemistry.

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Lisa E. Vaughan, J. Lieske, E. Bergstralh, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile.

Rachel A. Kudgus, Lisa E. Vaughan, J. Reid, 2019, The journal of sexual medicine.

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Lisa E. Vaughan, F. Anglani, J. Lieske, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women’s Health Study

Lisa E. Vaughan, K. Anderson, W. Thomas, 2016, Cancer Causes & Control.

Time in Therapeutic Range for Dialysis Patients on Warfarin: Determination and the Effect of Dietary Intervention.

R. Albright, Lisa Vaughan, Robert S. Niznik, 2020, Mayo Clinic proceedings.

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria

Lisa E. Vaughan, D. Assimos, J. Lieske, 2020, BMC Nephrology.

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort

Lisa E. Vaughan, J. Lieske, D. Milliner, 2020, International journal of molecular sciences.

Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort

Lisa E. Vaughan, D. Dingli, A. Dispenzieri, 2021, American journal of hematology.

Preeclampsia and ESRD: The Role of Shared Risk Factors.

Lisa E. Vaughan, A. Weaver, W. Rocca, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Risk of substance use disorders among adolescents and emerging adults with type 1 diabetes: A population‐based cohort study

A. Weaver, Seema Kumar, A. Creo, 2021, Pediatric diabetes.

The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.

Lisa E. Vaughan, R. Glassock, L. Cornell, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation

Lisa E. Vaughan, A. Weaver, V. Miller, 2018, Journal of the American Heart Association.

Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study

Lisa E. Vaughan, A. Weaver, E. Stewart, 2019, Acta obstetricia et gynecologica Scandinavica.

Uterine and Fibroid Imaging Analysis from the FIRSTT Study.

E. Stewart, G. Hesley, K. Gorny, 2021, Journal of women's health.

Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes

Lisa E. Vaughan, A. Rule, T. Vrtiska, 2019, Mayo Clinic proceedings.

Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy.

Lisa E. Vaughan, A. Weaver, M. Mielke, 2020, Journal of the American College of Cardiology.

Nuclear Magnetic Resonance Metabolomic Profiling and Urine Chemistries in Incident Kidney Stone Formers Compared with Controls

Lisa E. Vaughan, A. Rule, S. Macura, 2022, Journal of the American Society of Nephrology : JASN.

Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.

J. Lieske, P. Schulte, D. Milliner, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery

Michael J. Miller, Lisa E. Vaughan, A. Weaver, 2019, American journal of obstetrics and gynecology.

Quantitative prediction of stone fragility from routine single and dual energy CT: proof of feasibility

James C. Williams, Andrea Ferrero, Felicity T Enders, 2016 .

Quantitative Prediction of Stone Fragility From Routine Dual Energy CT: Ex vivo proof of Feasibility.

Ian McKeag, C. McCollough, A. Huang, 2016, Academic radiology.

Characteristics of Patients with End-Stage Kidney Disease in ADPKD

Marie E. Edwards, Lisa E. Vaughan, T. Kline, 2020, Kidney international reports.

Correlation of Behavioral Interviewing Performance With Obstetrics and Gynecology Residency Applicant Characteristics☆?>.

Lisa Vaughan, D. Breitkopf, M. Hopkins, 2016, Journal of surgical education.

Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria

Lisa E. Vaughan, J. Lieske, P. Schulte, 2023, The Journal of urology.